✦ LIBER ✦

Memantine in moderate to severe Alzheimer’s disease

✍ Scribed by Andrew Kertesz

Book ID: 107543275
Publisher: Springer
Year: 2003
Tongue: English
Weight: 67 KB
Volume: 3
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-003-0051-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Memantine in moderate to severe Alzheime

Memantine in moderate to severe Alzheimer’s disease: an observational post-marketing study

✍ Michael Rainer; A. Wuschitz; C. Jagsch; C. Erb; J.-J. Chirikdjian; H. A. M. Muck 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 284 KB

Memantine enhances autonomy in moderate

Memantine enhances autonomy in moderate to severe Alzheimer's disease

✍ Benoît Rive; Martine Vercelletto; Florence Delamarre Damier; John Cochran; Cléme 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Background Alzheimer's disease (AD) is the leading cause of dementia and its course renders patients functionally disabled. Memantine is the first drug to demonstrate a clinical benefit in the treatment of patients with moderately‐severe to severe AD. ## Objectives Our objective w

Memantine benefits functional abilities

Memantine benefits functional abilities in moderate to severe Alzheimer’s disease

✍ Bengt Winblad; S. Gauthier; D. Åström; K. Stender 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 210 KB

Memantine effects on behaviour in modera

Memantine effects on behaviour in moderately severe to severe Alzheimer’s disease: a post-marketing surveillance study

✍ Francesca Clerici; Nicola Vanacore; Antonietta Elia; Stefania Spila-Alegiani; Si 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 216 KB

Specific Functional Effects of Memantine

Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease

✍ Doody, R.; Wirth, Y.; Schmitt, F.; Möbius, H.J. 📂 Article 📅 2004 🏛 S. Karger AG 🌐 English ⚖ 222 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving